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President 
"If the human race wishes to have a prolonged 
and indefinite period of material prosperity, 
they have only got to behave in a peaceful and 
helpful v1ay toward one another." 
- Sir Winston Churchill 
Colleagues, 
Well, the first month of the new year is 
here and gone. We've had the first 
meeting of the Medical Executive 
Committee of the Lehigh Valley 
Hospital/Muhlenberg Hospital Center 
combined medical staff. Drs. Linda Blose, 
Hugo Twaddle, John Mannisi, and John 
Lang attended the meeting as the elected 
representatives from Muhlenberg Hospital 
Center. I'll be trying to have a 
presentation at the Medical Executive 
Committee each month regarding some 
issue Troika feels is relevant to the 
combined medical staff. 
At the January meeting, John Stavros 
presented the results of a survey of 385 
Lehigh and Northampton County patients 
and 1 00 "community leaders" about their 
perception of the Lehigh Valley Hospital. 
The report of this survey was 
predominantly positive. One of the 
notable points of the survey was that the 
hospital and its medical staff are not seen 
as being as "compassionate and caring" 
as some of the other hospitals in the area. 
Troika feels that this result needs to be 
addressed by the medical staff and that a 
plan needs to be formulated to try to 
(Continued on Page 2) 
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improve this perception. We will be helping to develop a 
program to address this issue. All of us on our daily clinical 
rounds need to take time to answer our patients' questions, 
make sure they understand their problems and our plans to 
diagnose and treat them, and be sure that we are trying to make 
their stay in the hospital as positive an experience as possible. 
Bob, Ed, and I will try our best to maintain timely communication 
with the medical staff. We will continue to use Medical Staff 
Progress Notes as our primary vehicle for communication. We 
are told that most physicians read the "Progress Notes" and will 
continue to use this as the major method of communication for 
large issues. Unfortunately, "Progress Notes" is only published 
monthly. There may be issues which require more rapid means 
of communication. 
This leads me to the subject of email. I know that many of the 
members of the medical staff do not use email, or do so only 
infrequently. Email is a convenient vehicle for rapid communi-
cation. Physicians can assign someone on their staffs to 
function as their "surrogate" to read and print out important 
email messages. I would recommend that if you don't use the 
email system regularly, you should assign a surrogate from 
your office to read your email frequently and print out 
important messages for you to read at your leisure. We will be 
using email to keep members of the medical staff informed 
about important and timely issues which need to be discussed 
before the next issue of Medical Staff Progress Notes is 
published. For those of you who do use email, Ed, Bob, and I 
would be glad to receive your messages via that route. 
In our professional clinical activities, I would also encourage all 
of us to try to maintain personal communication between our 
colleagues on the medical staff regarding our patients. As we 
tried to encourage several years ago in the "Guidelines for 
Consultations," the personal communication between 
physicians is vitally important in insuring excellent patient care. 
We can be much more efficient in caring for our patients if we 
communicate with our colleagues personally. Recently the 
practice of physicians writing the order, "Discharge patient if 
O.K. with Dr. X" has created confusion and has resulted in 
consternation between physicians, nurses, and patients. It 
would be much better if Dr. X called Dr. Y personally to 
discuss the possible discharge of a patient. I would 
encourage this practice as we try to deal with other physician 
colleagues and the nursing staff as the professionals we are. 
Telephone calls to our physician colleagues may take a little 
more time, but will result in better and more efficient patient 
care. It will also help to nurture closer professional relation-
ships between physicians. And, it's good for patient care! 
We will also be reinstituting the "Medical Staff/Administration 
Exchange Sessions" on an "as needed" basis so that 
members of the medical staff can provide input prior to ( 
important decisions being made. Hopefully, these sessions 
will provide an opportunity for interested members of the 
medical staff to present their views to members of the hospital 
administration. 
Over the next several months, I'll be inviting members of the 
medical staff to meet with me personally to discuss issues 
which they feel are important to themselves, the medical staff 
in general, and the hospital. I hope I'll be able to learn from 
these sessions so that Troika will be better able to address 
issues of importance to the medical staff. 
Finally for this month, I'd like to begin to address the 
organization of the Lehigh Valley Hospital patient medical 
record (chart). I've been concerned for some time that the 
present LVH patient chart does not appear to be "user 
friendly." It seems to me that there might be a better way for 
the medical record to be organized so that we as physicians 
would find the chart more useful and more efficient to use in 
our daily care of patients. Ed Mullin, as former chair of the 
Medical Records Committee, has also expressed this 
sentiment. There is no "correct" or required way for the patient 
chart to be organized. JCAHO does not specify how patient ( 
charts need to be ordered. Before we begin any attempt to . 
change the organization of the patient medical record, I'd like 
to have input from the medical staff as to whether you feel the 
present patient chart is organized in a way which is most 
useful to you on your daily rounds. If you agree {or disagree) 
with me that the patient charts might be better organized, 
please communicate your ideas and suggestions to me via 
email, letter, or hallway contact. I assure you that no change 
in the present medical record will occur unless there is a 
consensus from the medical staff that there should be a 
change. 
I hope you all have a good, safe, and healthy month of 
February. As we move ahead, let's try to consider Sir Winston 
Churchill's quote and apply it to our professional relationships. 
Remember, I'll be in the medical staff office on the second 
floor across from the OR lounge at Cedar Crest & 1-78 every 
Monday afternoon from 1 to 3:30 p.m., to meet with members 
of the medical staff who are interested in scheduling an 
appointment. Please call Beth Martin at 402-8980 to schedule 
an appointment. 
&rJJ 
David M. Caccese 
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Flu Update 
Influenza A has arrived! The following are a few notes to 
assist in the management of suspected and confirmed 
Influenza A patients in the hospital environment. 
=> Cases admitted to the hospital with influenza high on 
the differential list of diagnoses should be placed on 
Droplet Isolation (which requires a private room) 
immediately upon admission. 
=> Cases can be confirmed by viral culture or made 
clinically (high fever, severe myalgia, multiple cases, 
short [three day] incubation). Viral culture kits are 
available through the Outpatient Department, 
Emergency Departments, or by calling 402-8170. 
=> Rimantadine (Fiumadine) at 100 mg twice a day is 
helpful for prevention or therapy for Influenza Type A. 
Modify dosage to once a day for renal insufficiency 
and/or >65 years. 
=> Infection Control will notify the physicians of roommates 
of patients identified with influenza to alert them to the 
potential exposure. In these instances, it is 
recommended the physician inquire about vaccination 
history and watch for flu-like symptoms in unvaccinated 
patients. 
=> Patients vaccinated for influenza post exposure should 
be continued on Rimantadine for 14 days allowing for 
the vaccine to take effect. 
=:> Although the optimal time for influenza vaccination is 
October through mid-November, healthcare providers 
should continue to offer influenza vaccine up to and 
even after influenza activity has been detected in the 
community, particularly to those persons at high risk for 
influenza-related complications. 
Witnessing the admissions related to complications from 
influenza serves as a constant reminder of the need for high 
risk individuals to be placed on a yearly vaccination 
schedule for influenza by their health care provider. It also 
reminds us all of our responsibility as healthcare providers 
to be vaccinated as well to reduce the risk of transmission 
to our patients. 
If you have any questions, please contact the Infection 
Control Department at 402-0680. 
Physiatry Consults 
Some confusion was recently identified regarding the 
ordering of Physical Medicine and Rehabilitation or 
Physiatry consults vs. evaluation of patients for transfer to 
Good Shepherd (GSRH Eval), particularly in the 
Transitional Skilled Unit (TSU). 
When the attending physician orders an evaluation by the 
Good Shepherd nurse liaison for possible admission to 
Good Shepherd, it should be worded "Good Shepherd 
Nurse Liaison Eval" (776-3293). 
When the ordering physician orders a consultation with a 
physiatrist, the order should be worded "PMR (or physiatry) 
evaluation-- Dr. for Reason." Examples of 
reasons could include, but are not limited to "evaluate rehab 
needs and recommend appropriate care," "evaluate and 
recommend appropriate level of rehab care," or "evaluate 
falls/gait abnormalities and recommend treatment." 
Identifying the appropriate rehabilitation destination based 
on the many options available to your patients (TSU, 
Muhlenberg Rehabilitation Center, Affinity, other outpatient 
sites, comprehensive inpatient rehabilitation, and 
homecare) has become complicated and confusing. 
Physiatrists are available to assist you in educating your 
patients and their families regarding which of the many 
settings are appropriate based on their rehab needs. 
If you have any questions regarding this issue, please 
contact Jane Dorval, MD, Chief, Division of Physical 
Medicine & Rehabilitation, via e-mail or at 776-3340. 
Edgardo S.G. Cruz, MD Memorial Fund 
A memorial fund has been established in honor of our fnend 
and colleague, Edgardo S G. Cruz, fvlD The memorial fund 
will be divided up among Dr Cruz's favorite charitable 
organizations. Donations should be made payable to 
Susan Cruz. c/o The fvlemonal Fund of 
Edgardo S G. Cruz, rvlD 
American Bank 
4029 W. Tilghman Street 
Allentown. PA 18104 
The Cruz family deeply appreciates the expressions of 
sympathy and support they have rece1ved throughout this very 
difficult time. 
Medical Staff Progress Notes February, 1999 X Volume 11, Number 2 Page4 
Transfusion Medicine: HCV (Hepatitis C 
Lookback Notifications) 
In an attempt to identify persons at high risk for developing 
chronic liver disease, the Surgeon General, Centers for 
Disease Control, and the American Liver Foundation are 
recommending that patients who received transfusions prior 
to 1992 be tested for the presence of HCV antibodies. 
The first generation test for HCV was introduced in 1990, 
and most blood centers, including Miller Memorial Blood 
Center, had started testing donor blood immediately. A 
second generation test was introduced in 1992. The 
second generation test is at least 25% more sensitive than 
the first. It also eliminated a large number of false positive 
results seen with the first generation. 
In addition to this general advisory, a targeted lookback 
process has also been mandated by the Food and Drug 
Administration (FDA). In this targeted lookback, if a current 
blood donor tests positive for HCV, previous recipients of 
blood from this particular donor are identified and tested for 
HCV. All testing is done confidentially at the blood center 
free of charge. Informational letters to help with this testing 
and counseling are sent to the current or known health care 
provider of the patient. For patients with no known 
attending physician, a certified letter will be sent to the 
patient at their last known address. FDA mandates that 
transfusion services make at least three good faith attempts 
to notify the previous recipients of blood from donors who 
are now testing positive. 
For patients who are not part of the targeted lookback, 
testing should go through the normal laboratory channels as 
a part of a hepatitis profile or just HCV testing. The usual 
lab charges will apply. 
Lehigh Valley Hospital and Health Network is expecting a 
large number (300-500) of these lookback letters from the 
blood center. Our process will identify the recipients and 
notify the current attending physician or the physician of 
record first verbally and then be followed by a notification 
package containing all the materials required to complete 
this process. This process must be completed within a 
defined time period. 
The current risk for HCV is estimated to be approximately 
1:100,000. 
If you have any questions; please contact Bala B. Carver, 
MD, Medical Director, Transfusion Medicine, at 402-8142. 
Breast Health Services in Top 5% 
( 
Recently, Breast Health Services passed their FDA 
inspection for mammography accreditation with no 
contingencies. This places Lehigh Valley Hospital and 
Health Network's Breast Health Services among the top 5% 
in the nation who enjoy such success. 
The Mammography Quality Standards Act requires that 
mammography facilities undergo inspection by the 
Department of Health and Human Services (Food and Drug 
Administration) on an annual basis. The focus of the 
inspection included: equipment performance, technologist 
quality control, medical physicist survey, personnel 
qualifications, medical reports and outcome audits. There 
are defined standards in each of these areas which are 
thoroughly scrutinized by the inspectors during their annual 
visits. Additionally, patient satisfaction surveys performed 
nationwide by Press Ganey have placed Breast Health 
Services in the top 99.6%. 
Such results can only be achieved by a caring, successful 
team. The program is fortunate to have the strong 
leadership of Gregory R. Harper, MD, PhD, and Elisabeth 
Ladd, RN, MSN. The recent addition of John G. Pearce, ( 
MD, as Director of Breast Imaging and Associate Director 01 
Breast Health Services has allowed for rapid transition 
toward the ultimate goal of a comprehensive breast center. 
Prior to his arrival here, Dr. Pearce was the Director, 
Outpatient Department- Radiological Services at LAC/USC 
Medical Center, Los Angeles, Calif. He brings strong 
leadership to the mammography program and shares a 
vision in keeping with Lehigh Valley Hospital's strategic plan 
for growth. Dr. Pearce is an internationally known 
mammographer and educator, and his arrival has quickly 
promoted Breast Health Services at Lehigh Valley Hospital 
and Health Network into a leading role for modem breast 
health care in the community. 
The staff of Breast Health Services has increased 
community outreach by speaking to community groups 
including Allentown City Hall employees, Regional 
Technology in the Poconos, Encore Breast Cancer 
Survivors' Public Education Program of the YWCA, and the 
Nazareth Senior Center. Community involvement is critical 
to promote optimal breast health for the women of the 
Lehigh Valley. 
( 
Medical Staff Progress Notes Febrn!l'l, 1999 X Volume 11, Number 2 Page5 
( 
Ordering Mammography 
(o order and bill for mammography, the facility performing the 
study must provide information related to the type of study 
being performed and the diagnosis or chief complaint 
supporting the study. A screening mammogram is ordered for 
a patient for whom there is no suspicion of an underlying 
problem. Its purpose is to screen for an occult malignancy. 
Screening mammography is covered by Medicare and most 
insurers annually after age 40, though coverage may be 
subject to a deductible. The chief complaint for a screening 
study is "screening mammogram." NoV code or additional 
high risk information is to be submitted by current Medicare 
guidelines. 
Diagnostic mammography is ordered for those patients 
demonstrating a current breast symptom with an appropriate 
diagnosis code. The only V code which is acceptable when a 
diagnostic mammography is performed is V10.3, previous 
history of breast cancer. Please note that not all insurers 
consider fibrocystic disease (611.1) to be justification for a 
diagnostic mammography; in such cases the claim may be 
rejected by the patient's insurance. Similarly, screening 
studies performed on patients not meeting the guidelines set 
by their insurers may not be covered or may be subject to 
( aductibles even when a diagnosis of fibrocystic disease is 
provided. For Medicare and some other insurers, any code 
other than a V code is incompatible with a diagnostic study, 
resulting in a claim rejection. 
For this reason, it is advisable to list fibrocystic disease as the 
chief complaint only when the patient has a current problem. 
In these cases, a diagnostic mammography is an appropriate 
study. It is strongly recommended in such cases that the 
actual problem (e.g., pain or lump) be listed as the chief 
complaint to avoid coding problems which can result in 
claims denial. For those women with a history of 
fibrocystic disease and no current symptoms, a screening 
study with a chief complaint of screening mammogram 
(V76.12) is the more appropriate way to order 
mammography. 
Medicare now allows the radiologist to perform additional 
studies at the time of a patient's visit. Physicians may order a 
mammogram with ultrasound if indicated. For managed care 
patients, such an order can minimize the inconvenience to the 
patient and the primary care office of securing additional 
referrals to cover the ultrasound. Be assured that Breast 
- '-iealth Services will only perform the ultrasound if warranted 
\~._,JY the mammographic and/or clinical findings AND approved 
by the referring physician. 
For your convenience, Breast Health Services has prepared 
prescription blanks to facilitate effective ordering of 
mammograms. Prescription pads have been made available 
to most physicians who routinely order mammograms. If your 
office has not received a supply or if you need prescription 
pads, please call Breast Health Services at 402-0690. 
Wound Care Center@ at Muhlenberg 
Hospital Center Offers Monofilament to 
Physicians 
Virtually every primary care physician treats patients with 
diabetes. It is very likely that at least half of these patients 
have or will develop diabetic neuropathy. This most common 
complication of diabetes results in the loss of protective 
sensation which signals pain and helps patients avoid injuries. 
As a result: 
=> 15% of all people with diabetes will develop foot or leg 
ulcers. 
=> Patients with diabetes have a 15 fold increase in the risk 
of amputation. 
=> 42% of those amputated will require contralateral limb 
amputation in one to three years, and 56% in three to five 
years. 
Yet, studies show that a foot inspection is rarely part of the 
office visit - as little as 12% of the time. 
The American Diabetes Association estimates that diabetic 
related amputation could be reduced by 50% if patients were 
routinely tested for neuropathy, educated to prevent injury or 
complications, and fitted with appropriate footwear as needed. 
The Centers for Disease Control has issued a challenge to 
reduce the incidence of diabetes related amputation by 40% 
by the year 2000. At the Wound Care Center, everything is 
being done to reach that goal. The medical team uses the 
monofilament to test patients with diabetes during every visit 
to the Center. You are invited to do the same. Together, we 
can really make a difference. 
If you missed receiving a monofilament at our recent Open 
House, please contact Peg Cowden, Program Director, at 
882-2989 to receive your free monofilament. 
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Lehigh Valley Balance and 
Vestibular Program 
Beginning at the end of January, rehabilitation services of the 
Lehigh Valley Health Network began providing a new program 
for fall prevention, balance retraining, and vestibular 
rehabilitation. 
This new program -- the Lehigh Valley Balance and 
Vestibular Program - will focus on the evaluation of the 
patient's functional abilities and assessment of positions or 
movements that provoke the patient's symptoms. 
Initially, the Balance Master machine will be used as an 
integral part of the assessment of the patient. This state-of-
the-art system simulates six sensory conditions providing 
precise measurements of the body's performance. By 
measuring how much the body sways under different 
conditions, these tests can help to determine the nature of the 
balance disorder. Based on these findings, an appropriate 
therapy program is designed to minimize those symptoms, 
improve the patient's balance, teach compensatory strategies, 
and increase functional status to promote the return to normal 
activities. 
The Lehigh Valley Balance and Vestibular Program is 




• Balance Problems 
• Frequent Falls 
• Fear of Falling 
• Light-headedness 
This outpatient service will initially be provided at Muhlenberg 
Rehabilitation Center located at 2545 Schoenersville Road, 
Bethlehem, through physician referral only. Patients will be 
treated by physical therapists, with consultation services 
available from Occupational Therapy, Nutrition, and 
Pharmacy. 
It is the vision of rehabilitation services to provide a wellness 
program through a community outreach program which will 
provide fall risk assessments to residents of skilled nursing 
facilities, personal care facilities, and at health fairs. In 
addition, rehabilitation services envisions a partnership with 
the Lehigh Valley community of physicians to provide team 
management of the balance disorders in the region through a 
complete balance center. 
For more information or if you have any questions regarding 
this new program, please contact Michael Mueller, PhD, 
Administrator of Rehabilitation Services, at 861-2247. ( 
The Center for Health Promotion 
and Disease Prevention Relocates 
On January 28, the Helwig Diabetes Center and the LOVAR 
(Lowering of Vascular Atherosclerotic Risk) Research Office 
relocated to the fourth floor of Lehigh Valley Hospital, 17th & 
Chew. In addition, Gregory Salem, Operations and Marketing 
Manager for the Center for Health Promotion and Disease 
Prevention (HPDP) will be located here. Other members of 
the HPDP staff have moved to the new Health Center at 
Trexlertown, one of many community sites for service delivery. 
New telephone numbers include: 
Helwig Diabetes Center- (610) 402-4082 
LOVAR Research Office- (610) 402-4088 
Gregory Salem - (61 0) 402-4085 
The fax number for these offices is (61 0) 402-4078. 
Hours of operation for the Helwig Diabetes Center and LOVAR, 
are 8 a.m. to 5:30 p.m., Monday through Friday. Courtesy ( 
valet parking is available for patients weekdays from 6 a.m. to 
4:30 p.m. Parking is also available in the Visitor's Lot on the 
southwest comer of 17th & Chew and in the Fairgrounds 
Parking Lot. Entrances to both lots are on Chew Street. 
New Preprinted Orders for Gl Hemorrhage Patients 
Beginning December 8, 1998, Gl Hemorrhage packets 
have been available in the high and moderate acuity 
area of the Emergency Department at Cedar Crest & 
1-78. The packets contain preprinted orders designed 
to be used when the patient with a possible Gl 
hemorrhage is going to be admitted as an inpatient. 
These orders were developed by a multidisciplinary 
team chaired by Carl F. D'Angelo, MD, Chief, Division 
of Gastroenterology. The packet also contains 
admission progress record, procedure 
requesUconsent form, consent for transfusion of 
blood and/or blood products, clinical pathway, and 
the CareMap®. The packets are located in the file 
drawer that contains other preprinted orders and 
clinical pathways in each of the two areas mentioned ~ .. 
earlier. The Emergency Department staff will be able 
to assist admitting physicians to locate these packets. 
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· Art Show & Auction 
( 
Che Professional Nurse Council of Lehigh Valley Hospital 
and Health Network is joining forces with the Heisman 
Fine Arts Gallery, Inc., for "An Evening of Artful 
Elegance." This fund-raising art auction will be held on 
Friday, March 26, at Lehigh Valley Hospital and Health 
Network's new Health Center of Trexlertown. 
A preview of 200 custom-framed paintings, watercolors, 
serigraphs, lithographs, and etchings will start at 6:30 
p.m. The auction will begin at 7:30 p.m. 
Special highlights will include a "Collectors' Club Corner" 
featuring nationally and internationally known artists. 
Cost of admission is $15.00 per person which includes 
refreshments and musical entertainment. 
All proceeds from the event will benefit the "Friends of 
Nursing Program," a philanthropic foundation established 
to promote excellence in nursing practice, education, and 
research. 
For ticket or additional information, please contact the 
Professional Development Office at 402-1704. 
PLEASE HELP! 
Many physicians and other clinical staff are not 
using the card access doors to enter the 
Emergency Department from the Emergency 
Department waiting room. They are simply 
walking through the patient triage/registration 
area, many without obvious IDs. This 
"shortcut" compromises patient confidentiality 
and interrupts the triage nurse from his/her 
patient evaluation. 
PLEASE, when entering the Emergency 
Department, use the card access doors and 
efrain from using the triage/registration rooms 
s the access point. Thank you. 
Personal Protective Equipment Reminder 
Federal, state, and JCAHO regulations require 
that personal protective equipment (i.e., 
protective shoe coverings/blue booties) be 
removed before leaving the area of their intended 
use (operating room, cath lab, etc.). Failure to do 
so may result in the organization, as well as the 
individual(s), receiving costly citations for this 
unsanitary practice. 
Congratulations! 
Kevin E. Glancy, MD, Division of Trauma-Surgical 
Critical Care/General Surgery, was recently recertified as 
a diplomate of the American Board of Emergency 
Medicine. 
Daniel D. Goldfarb, MD, Department of Psychiatry, 
recently passed a stringent examination in Clinical 
Psychopharmacology and has been certified as qualified 
in this field by the American Society of Clinical 
Psychopharmacology, Inc .. 
Randy Jaeger, MD, Division of Orthopedic Surgery, was 
recently notified that he has become a Fellow of the 
American College of Surgeons. 
James G. McHugh, MD, Department of Emergency 
Medicine, was recently elected to Fellowship in the 
American College of Physicians. 
Jennifer E. Trottman, MD, Division of 
Hematology/Medical Oncology, has been appointed 
Acting Medical Director for the Allentown Office of Lehigh 
Valley Hospice. Dr. Trottman will be working with the 
Hospice team to provide medical leadership for the team, 
provide attending coverage with other physicians for 
patients who need attending service on the Hospice 
inpatient unit, and develop new initiatives in Hospice 
which will enhance the continuity and care management 
of Hospice patients. 
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Papers, Publications and 
Presentations 
"Linac Radiosurgery for ,Trigeminal Neuralgia," a paper co-
authored by George I. Chovanes, MD, Division of 
Neurological Surgery, Section of Neuro Trauma; Clinton H. 
Leinweber, DO, Department of Radiation Oncology; and Shih 
Min Lo, PhD, Radiation Physicist, was presented by Dr. 
Chovanes at the Fifth Annual Linac Radiosurgery meeting held 
on December 10 in Lake Buena Vista, Fla. This work 
represented the first published results utilizing linac-based 
radiosurgery for treating this chror''': disorder. The meeting 
was attended by over 300 neuros;,. .. geons, radiation 
oncologists, and physicists from the United States and 
Europe. 
lndru T. Khubchandani, MD, Division of Colon and Rectal 
Surgery, was an invited speaker at the Annual Meeting of the 
Association of Colon and Rectal Surgeons of India combined 
with the Association of Surgeons of India in Ahmedabad, India, 
on January 2. He gave a Guest Oration on the "Surgical 
Options in the Management of Inflammatory Bowel Disease." 
He also chaired a panel on "Management of Advanced Cancer 
of the Rectum." 
Dr. Khubchandani then traveled to Hong Kong where he was 
invited to participate in a one-day scientific symposium to 
inaugurate the Department of Colon and Rectal Surgery at the 
University of Hong Kong. His chosen subject for delivery there 
was "Colon and Rectal Surgery in Academia." 
Vincent R. Lucente, MD, Vice Chairperson, Department of 
Obstetrics and Gynecology, was one of the co-authors of an 
article, "Site-Sr,:.ecific Fascial Defects in the Diagnosis and 
Surgical Management of Enterocele," which was published in 
Volume 179, Number 6, Part 1, of the American Journal of 
Obstetrics and Gynecology. 
For Your Calendar 
There will be a general membership meeting of 
the Greater Lehigh Valley Independent Practice 
Association, Inc., on Tuesday, March 23, at 6 
p.m., in the hospital's Auditorium at Cedar Crest 
& 1-78. 
Physicians attending this meeting will receive 
credit toward the Incentive Plan. 
LOVAR (Lowering of Vascular Atherosclerotic Risk) 
Study Kick-Off will be held at Medical Grand Rounds 
on Tuesday, March 9, beginning at Noon, in the 
hospital's Auditorium at ~dar Crest & 1-78. 
The program, which will be presented by John E. 
Castaldo, MD, Principal Investigator, will include a 
comprehensive atherosclerosis outcomes based 
research initiative offered by Lehigh Valley Hospital's 
Center for Health Promotion and Disease Prevention. 
Upcoming Seminars, Conferences 
and Meetings 
Emergency Medicine Grand Rounds 
Emergency Medicine Grand Rounds will be held on Thursday, 
February 4, beginning at 9 a.m., in Classroom 1 at Lehigh 
Valley Hospital, Cedar Crest & 1-78. 
Topics will include: 
0 Pediatric EKG- William F. Bond, MD, Department of ( 
Emergency Medicine 
0 Tricyclic Overdose, etc.- Perry Fooskas, MD, Department 
of Emergency Medicine 
0 Diabetic Emergencies- Larry N. Merkle, MD, Chief, 
Division of Endocrinology/Metabolism 
For more information, please contact Judy Szep in the 
Department of Emergency Medicine at 402-7168. 
Medical Grand Rounds 
Medical Grand Rounds are held every Tuesday beginning at 
noon in the hospital's Auditorium at Cedar Crest & 1-78. 
Topics to be discussed in February include: 
0 February 2 - New Disease Modifying Agents in 
Rheumaioid Arthritis 
0 February 9 - The Survivorship Movement: Defining the 
Medical, Social & Political Parameters of Quality Cancer 
Care 
0 February 16 - Evidence Based Medicine 
0 February 23 - Insults to the Vessel Wall: Redefining 
Therapy for Cardiovascular Disease (. 
For more information, please contact Evalene Patten in the 
Department of Medicine at 402-1649. 
( 
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(Marsha A. Gordon, DDS) 
1050 S. Cedar Crest Blvd. 
Suite 104 
Allentown, PA 18103-5454 
(61 0) 433-5111 
Fax: (610) 433-4393 
( 1epartment of Dentistry 
uivision of Pediatric Dentistry 
Provisional Active 
Site of Privileges - LVH & MHC 
Maria Lynn Jones, MD 
(Robert M. Taxin, DO) 
7619 Tilghman Street 
Box487 
Fogelsville, PA 18051-0487 
(610) 395-1936 
Fax: (610) 395-7263 
Department of Medicine 
Division of Generallntemal Medicine 
Provisional Active 
Site of Privileges- LVH & MHC 
Zafar M. Magsi, MD 
Northern Valley Primary Care 
2014 Laubach Avenue 
Northampton, PA 18067-1770 
(610) 261-0999 
Fax: (610) 261-2187 
Department of Medicine 
>ivision of Generallntemal Medicine 
Provisional Active 
Site of Privileges - L VH & MHC 
February, 1999 X Volume ll, Number 2 
Change of Status 
Tamar D. Earnest, MD 
Department of Surgery 
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Division of General Surg~ry/Trauma-Surgical Critical Care 
From: Active/LOA 
To: Affiliate 
Kenneth M. McDonald, MD 
Department of Surgery 
Division of Vascular Surgery 
From: Active/LOA 
To: Honorary 
Leo W. Todd, Jr., DO 
Department of Family Practice 
From: Provisional Active 
To: Affiliate 
Change of Address 
Trexlertown Medical Center 
David G. Glueck, MD 
J. Stephen Long, MD 
Sophia J. Michailidis, DO 
Stephen J. Motsay, MD 
Brian D. Wilson, MD 
6900 Hamilton Blvd. 
P.O. Box 127 
Trexlertown, PA 18087-0127 
(610) 402-0101 
Fax: (610) 402-0102 
Eric D. Becker, MD 
1685 Valley Center Parkway 
Bethlehem, PA 18017 
(610) 882-2050 
Fax: (610) 882-3633 
Sarah J. Femsler, MD 
(No longer in practice with LVPG) 
501 N. 17th Street 
Suite 212 
Allentown, PA 18104-5687 
(61 0) 776-0900 
Abel A. Gonzalez, MD 
1685 Valley Center Parkway 
Bethlehem, PA 18017 
(610) 882-2050 
Fax: (610) 882-3633 
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Nora A. Suggs, MD 
322 S. 17th Street 
Allentown, PA 18104-6708 
(610) 439-4108 
Fax: (61 0) 435-4821 
Practice/Address Change 
Robert B. Kevitch, MD 
(No longer in practice with Plastic Surgeons Professional 
Group) 
(New practice- John A. Altobelli, MD, FACS, PC) 
1600 Lehigh Parkway East 
Allentown, PA 18103-3093 
(610) 437-2378 
Fax: (61 0) 820-9983 
Michael C. Sinclair, MD 
(No longer in practice with Panebianco-Yip Heart Surgeons) 
(New practice- Yeisley & Sinclair Cardiothoracic Surgery, 
LLC) 
1240 S. Cedar Crest Blvd. 
Suite 305 
Allentown, PA 18103-6218 
(610)437-1430 
Fax: (610) 437-1782 
Two-Year Leave of Absence 
Karen M. Matz, MD 
(College Heights OBGYN Associates, PC) 
Department of Obstetrics and Gynecology 
Division of Primary Obstetrics and Gynecology 
From: Active 
To: Active/LOA 
(1/1/99 to 12/31/2000) 
Resignations 
Attila G. Devenyi, MD 
(Milton S. Hershey Medical Center) 
Department of Pediatrics 
Division of General Pediatrics 
Douglas G. Field, MD 
(Milton S. Hershey Medical Center) 
Department of Pediatrics 
Division of Gastroenterology 
Peter H. Goldman, MD 
(Peter H. Goldman, MD- Family Practice) 
Department of Family Practice 
Michael J. Lambo, MD 
(Allentown Radiation Oncology Associates) 
Department of Radiation Oncology 
Gene W. Miller, DO 
(08-GYN Care, Inc.) 
Department of Obstetrics and Gynecology 
Division of Primary Obstetrics and Gynecology 
Chandrakant C. Shah, MD 
(Mertztown Community Medical Center) 
Department of Medicine 
Division of General Internal Medicine 
John S. Stevens, Jr., DO 
(08-GYN Care, Inc.) 
Department of Obstetrics and Gynecology 
Division of Primary Obstetrics and Gynecology 
Steven J. Wassner, MD 
(Milton S. Hershey Medical Center) 
Department of Pediatrics 
Division of Nephrology 
Deaths 
Edgardo S. Cruz, MD 
(Allentown Anesthesia Associates, Inc.) 
Department of Anesthesiology 
11/6/98 
Robert E. Lentz, MD 
Department of Family Practice 
Honorary 
10/19/98 
Allied Health Professionals 
Appointments 
Christopher T. Bishop, CST 
Physician Extender 
Technical- Surgical Technician 
(Valley Sports & Arthritis Surgeons - Neal A. Stansbury, MD) 
Carol E. Bouchard, CST 
Physician Extender 
Technical- Surgical Technician 
( 
( 
(Lehigh Valley Ophthalmic Associates- Alan D. Listhaus, MD( 
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Molly J. Breslin, GRNA 
(
. Physician l;xtender 
. 'rofessional - GRNA 
(Allentown Anesthesia Associates, Inc. -Alphonse A. Maffeo 
MD) I 
Michael T. Butler, PA·C 
Physician Extender 
Physician Assistant - PA-C 
(Yeisley & Sinclair Cardiothoracic Surgery, LLC- Geary L. 
Yeisley, MD) 
Amber J. Herring 
Physician Extender 
Technical - Dental Assistant 
(Marsha A. Gordon, DDS- Marsha A. Gordon, DDS) 
Kenneth P. Rachwal, PA·C 
Physician Extender 
Physician Assistant - PA-C 
(Coordinated Health Systems - Carl B. Weiss, Jr., MD) 
John F. Schell, CRNA 
Physician Extender 
Professional - CRNA 
(
. 'Allentown Anesthesia Associates Inc. -Alphonse A. Maffeo 
.v1D) ' 
( 
Change of Supervising Physician 
Sherri S. Delgado, CRNP 
Physician Extender 
Professional- CRNP 
From: John J. Cassel, MD 
To: Michael D. Pasquale, MD- LVPG-Trauma Surgery 
Catherine E. Donati, CRNP 
Physician Extender 
Professional - CRNP 
From: Gregory R. Harper, MD - Oncology Specialists of 
Lehigh Valley 
To: Clifford H. Lyons, MD- Hamburg Family Practice Center 
Patricia L. Donley, RN 
Physician Extender 
Professional - RN 
(ABC Family Pediatricians) 
From: Pasquale J. Fugazzotto, MD 
To: Scott M. Brenner, MD 
Additional Supervising Physician 
Edwin M. Straub 
Physician Extender 
Technical- Surgical Technician 
(Orthopaedic Associates of Allentown- Peter A. Keblish Jr. 
MD) ' ' 
Additional Supervising Physician - Neal A. Stansbury, MD -
Valley Sports & Arthritis Surgeons 
Change of Status 
Neil B. Laudenslager, PA 
Physician Extender 
(Orthopaedic Associates of Allentown -James C. Weis, MD) 
From: Physician Assistant 
To: Surgical Technician 
Resignations 
Charles P. Farley, CRNA 
Physician Extender 
Professional - CRNA 
(Allentown Anesthesia Associates Inc.) 
Dennis C. Frederick, PA·C 
Physician Extender 
Physician Assistant- PA-C 
(Orthopaedic Associates of Allentown) 
Deborah Logan, CNM 
Physician Extender 
Professional - Certified Nurse Midwife 
(M. Bruce Viechnicki, MD & Associates, PC) 
Todd B. Manley 
Physician Extender 
Technical- Anesthesia Tech Assistant 
(Allentown Anesthesia Associates Inc.) 
James J. Prudente, CRNA 
Physician Extender 
Professionai-CRNA 





THERAPEUTICS AT A GLANCE 
The following actions were taken at the December, 1998 Therapeutics Committee Meeting- Rebecca Hockman, Pharm.D., 
BCPS, Christopher Moore, R.Ph., Joseph Ottinger, R.Ph., MS, MBA 
DACLIZUMAB COMES 
TO L VH FORMULARY 
Daclizumab (Zenapax® by Roche 
Pharmaceuticals) is a humanized IgG1 
monoclonal antibody indicated for use with 
cyclosporine and corticosteroids to 
prophylax against acute organ rejection in 
renal transplant recipients. Daclizumab 
acts as an interleukin-2 (IL-2) receptor 
antagonist by binding to the Tac subunit(~ 
chain) of the high affinity IL-2 receptor. 
This receptor is found on the majority of 
activated T cells and is necessary to 
maintain the T cell activation. Daclizumab 
offers a different therapeutic option for 
induction therapy in renal transplantation, 
replacing the use of Orthoclone OKT3® 
(OKT3, Muromonab-CD3) in some 
patients. 
OKT3, a murine monoclonal antibody, 
inhibits CD3 on human T cells, which is 
- partly responsible for antigen recognition 
in T cells. OKT3 successfully inhibits the 
majority of T cell functions. OKT3 is 
used as prophylaxis against acute organ 
rejection in renal transplant recipients, and 
is used in the treatment of organ rejection. 
Important downfalls with OKT3 include 
the following: 1) the production of 
antibodies following drug administration 
and 2) the potential for the adverse effects 
of cytokine release syndrome (CRS). 
Antibody production to OKT3 may result 
in decreased efficacy if OKT3 is used in 
subsequentrejection episodes. The CRS 
may include adverse effects ranging from 
fever and chills to life threatening events 
such as pulmonary edema, cardiovascular 
collapse, seizures, and coma. 
Daclizumab offers two therapeutic 
advantages compared to OKT3. First, it is 
a different agent to use to prevent acute 
rejection at renal transplantation, and may 
allow OKT3 use to be preserved for the 
treatment of acute rejection. Secondly, 
there are no reports of CRS to date. 
Disadvantages include its lack of utility in 
the treatment of acute rejection, the lack of 
comparative data with OKT3, and cost 
(see below). 
Criteria for patient selection for 
daclizumab use have been discussed by the 
Renal Transplant Review Board, and 
approved by the Therapeutics Committee 
with the formulary addition of the agent. 
The L VH renal transplant patients in 
whom daclizumab will be used include the 
following: 
1) Patients undergoing a repeat renal 
transplant, having previously 
received OKT3 
2) Patients at high risk for CRS (i.e. 
elderly, cardiovascular dysfunction, 






L VH Cost/ Unit 
$347.11/ 25 mg 
$600.001 5 mg 
$240.001 2 mg 
LVH Cost/ 75 kg 
$1041.33 
$600.00 
L VH Cost/ Course of Therapy 
$5206.65/ 5 doses 
$6000.001 10 doses 
$240.00 $2400.00/ 10 doses 
Page 13 
RELAX AND CONSIDER 
THE ALTERNATIVES -
TIZANIDINE 
Tizanidine (Zanaflex), a clonidine 
derivative, is a centrally acting skeletal 
muscle relaxant with alpha2-adrenergic 
activity. It increases presynaptic inhibition 
and decreases alpha motorneuron 
excitability. Its main action is at an 
unidentified supraspinal site where it 
depresses activity of descending 
coeruleospinal effects in the brain stem 
and impairs release of excitatory amino 
acids from spinal intemeurons. 
Tizanidine is indicated for the acute and 
. intermittent management of increased 
muscle tone associated with spasticity. 
The reduction in muscle tone that occurs 
with tizanidine has its peak effect 1 to 2 
hours after dosing and the effect dissipates 
between 3 to 6 hours. Use should be 
individualized to correspond to activities 
and times when relief of spasticity is most 
important and titrated to avoid intolerance. 
It has primarily been evaluated in . 
spasticity associated with multiple sclerosis 
and spinal cord injury. Tizanidine may 
also be effective in the treatment of 
spasticity associated with chronic 
myelopathy, syringomyelia and 
hemiplegia; muscle spasm associated with 
acute low-back pain; stiff-man syndrome; 
neuropathic pain states; chronic tension-
type headaches; and may play a role in the 
management of morphine and heroin 
dependence. 
Following oral administration tizanidine is 
completely absorbed; however, oral 
bioavailability is only approximately 40% 
due to extensive frrst-pass metabolism. 
Food increases the peak concentration by 
approximately one-third and shortens the 
time to peak by approximately 40 minutes; 
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however, the extent of absorption is not 
affected. Plasma protein binding is low ( 
(30%). The elimination half-life of 
tizanidine is approximately 2.5 hours. 
Approximately 95% of the administered 
dose is metabolized. Urinary excretion of 
unchanged drug within 24 to 72 hours is 
0. 4% to 2. 7 % of the administered dose. 
The most common adverse reactions 
include drowsiness and dry ·mouth. Other 
reactions include dizziness, fatigue, 
flushing, depression, urinary incontinence, 
urine retention, dysarthria, muscle 
weakness, sleep disorders, bradycardia, 
hypotension and gastrointestinal 
disturbances. Tolerance to the sedation or 
other adverse effects does not appear to 
occur. Sedation is sometimes severe and 
can interfere with daily activities. It 
appears to be dose related. Dose-related 
retinal degeneration and corneal opacities 
were observed in animal studies with 
tizanidine. Such effects have not been ( 
observed in clinical trials. In clinical · 
trials, approximately 5 % of patients treated 
had elevations of liver function tests to 
areater than 3 times the upper limit of e> 
normal. Monitoring of aminotransferase 
levels is recommended during the first 6 
months of therapy and periodically 
thereafter. 
Hypotension may occur when tizanidine is 
used in combination with antihypertensive 
medications. Alcohol increased the AUC 
of tizanidine by approximately 20% and 
increased its peak concentration by 
approximately 15%. This was associated 
with an increase in side effects with 
tizanidine. In addition, the CNS 
depressant effects of alcohol and tizanidine 
are additive. Sedation is also likely to be 
additive when tizanidine is used in 
combination with other CNS depressants. 




in women taking oral contraceptives. 
Tizanidine should be used with caution in 
this population and initial tizanidine doses 
should be reduced. 
Effects are dose related; therefore, treatment 
should begin with a single oral dose of 4mg 
and the dose should be increased in 2 to 4mg 
increments as needed. The dose can be 
repeated at 6 to 8-hour intervals, although 
the manufacturer recommends a maximum of 
three doses in 24 hours. The total daily dose 
should not exceed 36mg. Lower initial doses 
are recommended in patients with renal 
insufficiency and in women on oral 
contraceptives. Baclofen (Lioresal) is 
currently the only similar agent available. It 
is expected that Tizanidine will be utilized in 
those patients unable to tolerate baclofen. 
The cost of Zanaflax is substantially more 
than generic baclofen (AWP $1.05 per 4mg 




The Therapeutics Committee, December 
meeting, approved the discontinuation of 
the automatic substitution policy for 
Augmentin® 875 mg (amoxicillin 875 mg/ 
clavulanic acid 125 mg/tab) po Q12H to 
Augmentin® 500mg (am.oxicillin 500 
mg/clavulanic acid 125 mg/tab) po Q8H. 
The daily dose of clavulanic acid is 
reduced with the Augmentin® 875 mg 
Q12H regimen. The reduction in 
clavulanic acid has the potential for 
decreased GI side effects. The L VH cost 
of each regimen is similar with 
Augmentin® 500 mg po Q8H at $7.08/day 
and Augmentin® 875 mg po Q12H at 
$7.061 day. Effective immediately, 
medication orders for Augmentin® 875 mg 
or Augmentin® 500 mg will be dispensed 




In addition to the well known shortages of 
albumin and IV immune globulin, several 
other products have recently joined this 
growing list with no discernible end in sight. 
Schein Labs, the primary manufacturer of 
generic metoprolol (Lopressor®) injection, 
has discontinued its manufacturing 
operations related to this product. This 
company had been the largest supplier of all 
metoprolol injection in the USA and its 
absence has not been offset by any other 
vender to date. Novartis, the manufacturer 
ofLopressor injection, has not been able to 
"ramp-up" production to date, and because 
of declining market share, its depot supplies 
have not been sufficient _to satisfy demand. 
Therefore, periodic shortages ofthis agent 
are expected to continue for the next several 
months. Alternatives include use of the oral 
product, injectable propranolol, or in 
selected cases, the use of atenolol injection. 
Currently, aletnolol (Tenonnin®) injection 
only has indications for a one time dose 
followed by immediate conversion to oral 
atenolol. 
Phenobarbital injection is also not available 
for an indeterminate time due to a scarcity 
of raw materials. Oral products are not 
affected at the current time. A 
recommendation for alternative agents 
would be contingent on the type of seizures 
that are being treated. 
Urokinase (Abbokinase) shortages are the 
result of an FDA concern related to aspects 
of the manufacturing process utilized for 
this product. The company (Abbott) has 
been unable to release any of the 12lots of 
product that were prepared. Abbott and the 
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FDA are working closely to resolve this 
issue as quickly as possible, but this activity 
has been ongoing since November 27, 1998. 
A company spokesperson indicated that a 
resolution date was "difficult to predict". 
An allocation system had been established, 
but was quickly overwhelmed. The 
Pharmacy has not received any shipments 
since early-December and our supplies at 
this writing are negligible. 
The Department of Pharmacy continues to 
make every effort to secure all of the above 
agents as they become available and is in 
constant contact with the various suppliers 
involved. 
pt\1298.hi 








Health Librazy and Learning Center 
(HLLC) at Trexlertown Health Mall will 
be opening this month. 
HLLC is a state-of-the-art health 
information library with health care 
professionals on staff ready to help with 
any health questions. Patient learning 
will be tailored to meet diverse needs and 
styles through a multi-media approach. 
Information on a variety of health topics 
will be available through computer 
access, videos, books, brochures, 
individualized self-care information 
' 
classes, support groups, and seminars. 
For more information about the HLLC or 
for a tour, please contact Deb Swavely, 
L VHHN Patient Education Specialist at 
402-8478 or HLLC at 402-0180. 
Symposium Announcement: 
Sixth Annual Update on Heart and Lung 
Surgery will be held on Saturday, April 
10, 1999 in the L VH Cedar Crest 
Auditorium. 
Agenda: 
7:30a.m. Registration and Continental 
Breakfast 
8:00 a.m. Opening Remarks & Special 
Presentation 
8:15 a.m. Thoracoscopic Minimally 
Invasive Lobectomy 
8:50a.m. Heartport Minimally Invasive 
Coronary Artery Bypass Grafting 
1 
9:25 a.m. Off-Pump Sternotomy and 
Minimally Invasive Beating Heart 
Coronary Artery Bypass Grafting 
10:00 a.m. Panel Discussion on 
Minimally Invasive Heart and 
Lung Surgery 
10:15 a.m. Break and Exhibits 
10:30 a.m. Update on Ventricular Assist 
Devices and the Artificial Heart 
11 :05 a.m. Discussion 
11 : 10 a.m. Stentless Aortic Valves 
11:45 a.m. Discussion 
11:50 a.m. Summary and Closing 
Remarks 
12:00 p.m. Adjournment, Buffet 
Luncheon, Exhibits 
Faculty includes: 
RobertS. Boova, :MD Chief, Division of 
Cardiothoracic Surgery Bryn Mawr 
Hospital & Systems Chief, Cardiac 
Surgery Jefferson Main Line Hospital 
System 
G. Michael Deeb, :MD, Professor of 
Surgery, Director of Adult Cardiac 
Surgery, University of Michigan Health 
Systems 
James D. Fonger, :MD, Director of 
Cardiac Surgery, Washington Adventist 
Hospital 
Ralph J. Lewis, :MD, Clinical Professor 
of Surgery, Chief: Thoracic and 
Cardiovascular Surgery, St. Peter's 
Medical Center-Robert Wood Johnson 
University Hospital University of 
Medicine and Dentistry of New Jersey 
Page 17 
D. Lynn Morris, MD, Associate 
Professor of Clinical Medicine 
Penn State University College of 
Medicine & Chief, Division of 
Cardiology, L VH 
Raymond L. Singer, MD, Clinical 
Assistant Professor of Surgery 
Penn State University College of 
Medicine & Associate Chief, Division of 
Cardiothoracic Surgery, L VH. 
For more information or to register, 
please contact Bonnie Schoeneberger via 
Email or phone at (610) 402-1210. 
Continuing Education: 
See the following calendar for all grand 
rounds and tumor boards. 
News from the Library: 
The Library is accepting 1998 "PDRs" 
for redistribution. When you receive 
your 1999 "PDR," please keep the 
Library in mind. We have a list of 
departments that use "PDRs" 
infrequently and, therefore, do not need 
to purchase a new one. 
OVID/PubMed TRAINING. 
To schedule a one-on-one OVID 
(MEDLINE) training session, call 
Barbara Iobst in the Health Sciences 
Library at 402-8408 between 8:30a.m.-
5:00p.m., Monday-Friday. Barbara can 
also instruct you in the use ofPubMed, a 
free, Web-based MEDLINE service 
offered by the National Library of 
Medicine (NLM). MEDLINE can be 
searched directly using PubMed. 
2 
New Books- Cedar Crest & I-78. 
"The Heart: Physiology, From Cell to 
Circulation," 3rd edition. 
Author: L. Opie WG 202 061h 
(Reviewed in the Dec. 24th issue of "The 
New England Journal of Medicine") 
"Improving Patient Satisfaction Now: 
How to Earn Patient and Payer Loyalty" 
Author: A. Nelson, et al. W 85 134 1997 
"Principles and Practice of Surgery for 
the Colon, Rectum, and Anus," 2nd ed 
Author: P. Gordon, WI520 G664p 1999 
New Books - 17th & Chew. 
"Seminars in Perinatology" Topic: 
"Endocrine Disorders in Pregnancy" 
Guest Editor: P. Gamer Vol. 22, No.6 
"Psychiatric Clinics ofNorth America" 
Topic: "Diagnostic Dilemmas, Part II" 
Guest Editor: David Tomb Vol. 21, No.4 
"Loss During Pregnancy or in the 
Newborn Period: Principles of Care with 
Clinical Cases and Analyses" Author: J. 
Woods, et al. WQ 225 W895d 1997. 
News from the Office of 
Educational Technology: 
Internet Workshop: 
Internet workshops focusing on how to 
use the internet to search and access job 
related information will be held in 
JDMCC Suite 401 on: 
February 9 - 9:30 am- 12 Noon 
February 12 - 9:30 am- 12 Noon 
February 17 - 1:00 pm- 3:30 pm. 
To register E-mail Chris Sarley or phone 
at 402-1641. 
Any questions, concerns or comments on articles from 
CEDS, please contact Sallie Urffer 402-1403 
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Medical Std h,gg'US Rates 
Grand Round and 
Tumor Board Schedule 
SUNDAY MONDAY 
12 Noon CIR Tumor Board 
- JDMCC - CR1 AlB 
7 
14 12 Noon CIR Tumor Board 




1 7 am Surgleal Grand Rounds -
CC·Aud - Surgical Critical Care 
8am Pediatric Grand Rounds • 
17-Aud 
12 Noon Medical Grand Rounds 
CC-Aud • New Disease 
Modifying Agents In Rheumatoid 
ArthrHis 
8 7am Ambulatory Clin Guideline 
Dev-SON 
7 am Surgical Grand Rounds -
CC·Aud - CIR Resident 
8am Pediatric Grand Rounds -
17-Aud 
12 Noon Medical Grand Rounds 
CC-Aud 
IS 7 am Surgical Grand Rounds -
CC-Aud -Oral Surgery 
8am Pediatric Grand Rounds -
17-Aud 
12 Noon Medical Grand Rounds 
CC·Aud - Evidence Based 
Medicine 
22 7 am Surgleal Grand Rounds • 
CC-Aud - Plastic Surgery 
Sam Pediatric Grand Rounds • 
17-Aud 
12 Noon Medical Grand Rounds 
CC-Aud -Insults to Vessel Wall: 
Redefining Therapy for CV 
Disease 
12 Noon Urology Tumor Board-




2 3 12 Noon Combined Tumor 
Board - JDMCC • CR1 AlB 
9 12 Noon Pulm Tumor 10 12 Noon G.l. Tumor Board 
Board- JDMCC • CR1 AlB - JDMCC· CR1 AlB 
16 17 12 Noon Combined Tumor 
Board· JDMCC • CR1 AlB 
23 24 12 Noon Cancer Comm. -
JDMCC· CR1 AlB 
Any questions, concerns or comments on articles from CEDS, please contact Sallie Urffer 402-1403 
FRIDAY 
4 7 am GYN Tumor Board/OBGYN 
Grand Rounds -17 Aud 
12 Noon Breast Tumor Board· 
JDMCC- CR1 AlB 
11 7am OBGYN Grand Rounds -17 
Aud 
12 Noon Pediatric Noon Conf • 
17Aud 
12 Noon Breast Tumor Board· 
JDMCC·CR1AIB 
18 7am OBGYN Grand Rounds -17 
Aud 
12 Noon Breast Tumor Board-
JDMCC· CR1 AlB 
25 7am OBGYN Grand Rounds -17 
Aud 
12 Noon Pediatric Noon Conf • 
17Aud 
12 Noon Breast Tumor Board-
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Medical Staff Progress Notes 
is published monthly to 
inform the Medical Staffs of 
Lehigh Valley Hospital and 
Muhlenberg Hospital Center 
and employees of important 
issues concerning the 
Medical Staffs. 
Articles should be submitted 
to Janet M. Seifert, Physician 
Relations, Lehigh Valley 
Hospital, Cedar Crest & 1·78, 
P.O. Box 689, Allentown, PA 
18105·1556, by the 15th of 
each month. If you have any 
questions about the 
newsletter, please call Mrs. 
Seifert at 402·8590. 
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